d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A phase II trial evaluating intra-hepatic chemotherapy with oxaliplatin every second week in combination with systemic gemcitabine and capecitabine in combination with cetuximab in patient with non-resectable liver metastases from cholangiocarcinoma [Country] DK [Cancer type] 
Cholangiocarcinoma
Nordic NECT - Inclusion completed
Cancer type